Skip to content

Archives of Disease in Childhood

ISSN 0003-9888

4 papers in the library · 2 citations · publishing 1985-2025

Papers

Sort Most recent Most cited

‘They’re creepy creatures with human-like features’: children’s experiences of visual hallucinations in Charles Bonnet syndrome—a qualitative study

Archives of Disease in Childhood 2025 L. Jones, Lara Ditzel-Finn, Leanne McDonald et al.

Objective Charles Bonnet syndrome (CBS) refers to the presence of visual hallucinations occurring secondary to visual impairment. The aim of this study was to understand the phenomenology of CBS in children and assess the emotional impact and support needs of patients and their families. Design Semistructured qualitative interview study. Setting UK. Participants Children (7–15 years) with an...

17 Microdosing/microtracer based pediatric drug development

Archives of Disease in Childhood June 1, 2023 Esther van Duijn, Steven Erpelinck, Wouter Vaes

Introduction: An overview is given on the use of microdosing/microtracing studies for the safer and faster development of drugs in children. In a microdosing study a very small amount of radiolabelled (often 14C) drug is administered to a human volunteer. Using accelerator mass spectrometry extremely low amounts of the drug and metabolites can be traced and quantified. Methods: Several...

IS-019 The Emergence Of Consciousness

Archives of Disease in Childhood October 1, 2014 H. Lagercrantz

The first breaths of air have since antique time been regarded as the ignition of life as indicated by the word spirits. The newborn becomes animated in this way – i.e. the emergence of consciousness. In modern time a bioethics committee1 has stated that when the new-born encompasses the capacity to breathe either independently, or with the support of a ventilator is the moral and legal point...

Neck radiographs in croup syndrome

Archives of Disease in Childhood March 1, 1985 I A Auchterlonie, B. Benjamin 2 citations

1141 Objectives: The ayahuasca effect refers to the potentiation of action of hallucinogenic tryptamine alkaloids by co-administration of a plant extract containing MAO inhibitors, especially the beta-carboline harmine. The hallucinogenic tryptamines in the ayahuasca drink are primarily DMT and 5-MeO-DMT, the same tryptamines in extracts of Bufo skin, and the snuff yopo, another South American...